Basilea Revenue and Competitors
Estimated Revenue & Valuation
- Basilea's estimated annual revenue is currently $36.6M per year.
- Basilea's estimated revenue per employee is $143,000
Employee Data
- Basilea has 256 Employees.
- Basilea grew their employee count by 8% last year.
Basilea's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Clinical Operations | Reveal Email/Phone |
3 | Head Controlling | Reveal Email/Phone |
4 | Head Global Market Access, Market Research and New Product Commercialization | Reveal Email/Phone |
5 | Head Clinical Operations | Reveal Email/Phone |
6 | Head Global Quality Management | Reveal Email/Phone |
7 | Head Global Human Resources | Reveal Email/Phone |
8 | Head Patents | Reveal Email/Phone |
9 | Head Analytics | Reveal Email/Phone |
10 | Head Chemical Development & Production | Reveal Email/Phone |
Basilea Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 26 | -4% | $15.7M | N/A |
#2 | $1.4M | 21 | -50% | $21.2M | N/A |
#3 | $41.9M | 293 | 8% | $6M | N/A |
#4 | $6M | 53 | -22% | $216.8M | N/A |
#5 | $0M | 2 | 0% | $33.3M | N/A |
#6 | $26M | 182 | 0% | N/A | N/A |
#7 | $30.9M | 221 | -26% | $64.6M | N/A |
#8 | $28.6M | 205 | -22% | $46.8M | N/A |
#9 | $249.1M | 1340 | 15% | $75M | N/A |
#10 | $12.4M | 95 | 3% | N/A | N/A |
What Is Basilea?
Basilea is a revenue-generating, commercial-stage Swiss biotech company. Our activities are focused in the areas of oncology, hospital antibiotics and hospital antifungals. Our portfolio comprises of two marketed anti-infective brands (Cresemba® and Zevtera®) and three oncology drug candidates in development. We are building on our potential for sustainable growth and valuation generation, based on increasing revenues and selective investments into internal and external innovation. Basilea was founded in 2000 as a spin-out from Roche and is headquartered in the heart of the life sciences hub of Basel. The Basilea group currently has 220 employees. Since 2004, Basilea is listed on the SIX Swiss Stock Exchange with the ticker symbol BSLN.
keywords:N/AN/A
Total Funding
256
Number of Employees
$36.6M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $58M | 257 | 5% | N/A |
#2 | $38M | 288 | 35% | N/A |
#3 | $57M | 294 | -7% | $2.1B |
#4 | $104M | 308 | 7% | N/A |
#5 | $93M | 338 | 32% | N/A |